Evidence map›Paper›PMID 32711474›Full record

ArticleBMC infectious diseases2020

Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.

Samara Tatielle Monteiro Gomes, Ednelza da Silva Graça Amoras, Érica Ribeiro Gomes, Maria Alice Freitas Queiroz, Edivaldo Costa Sousa Júnior, Janaína Mota de Vasconcelos Massafra, Poliana da Silva Lemos, João Lídio Vianez Júnior, Ricardo Ishak, Antonio Carlos Rosário Vallinoto

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Samara Tatielle Monteiro GomesLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil.
Ednelza da Silva Graça AmorasLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil.
Érica Ribeiro GomesLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil.
Maria Alice Freitas QueirozLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil.
Edivaldo Costa Sousa JúniorHealth Surveillance Department, Ministry of Health (IEC-SVS/MS), Evandro Chagas Institute, Ananindeua, Brazil.
Janaína Mota de Vasconcelos MassafraHealth Surveillance Department, Ministry of Health (IEC-SVS/MS), Evandro Chagas Institute, Ananindeua, Brazil.
Poliana da Silva LemosHealth Surveillance Department, Ministry of Health (IEC-SVS/MS), Evandro Chagas Institute, Ananindeua, Brazil.
João Lídio Vianez JúniorHealth Surveillance Department, Ministry of Health (IEC-SVS/MS), Evandro Chagas Institute, Ananindeua, Brazil.
Ricardo IshakLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil.
Antonio Carlos Rosário VallinotoLaboratory of Virology, Biological Science Institute, Federal University of Pará (ICB/UFPA), Ananindeua, Brazil. vallinoto@me.com.ORCID http://orcid.org/0000-0003-1135-6507
Universidade Federal do Pará · BRMinistério da Saúde · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 301869/2017-0Fundação Amazônia Paraense de Amparo à Pesquisa PRONEX-2015
6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV-1) infection is characterized by high viral replication and a decrease in CD4

methodsThe aim of the present study was to describe virological and immunological risk factors among HIV-1-infected individuals according to characteristics of progression to AIDS. The sample included 30 treatment-naive patients classified into three groups based on infection duration (> 6 years), CD4

resultsViral samples were classified as HIV-1 subtypes B and F. Greater selection pressure on mutations was observed in the group of viremia controllers, with a higher frequency of immunological escape mutations in the genes investigated, including two new mutations in gag. The viral sequences of viremia controllers and nonviremia controllers did not differ significantly regarding the presence of immune escape mutations.

conclusionThe results suggest that progression to AIDS is not dependent on a single variable but rather on a set of characteristics and pressures exerted by virus biology and interactions with immunogenetic host factors.

Indexed as

Acquired Immunodeficiency SyndromeAdultBrazilCD4-Positive T-LymphocytesCross-Sectional StudiesFemalegag Gene Products, Human Immunodeficiency VirusGenes, gagHIV-1HumansImmune EvasionMaleMutationPhylogenyProtein ConformationRetrospective Studiesgag Gene Products, Human Immunodeficiency VirusEscape mutationsHIV-1Viremia controllers

Identifiers

PMID32711474
PMCPMC7382849
OpenAlexW3045243130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.